Roel Sentjens

1.5k total citations
12 papers, 400 citations indexed

About

Roel Sentjens is a scholar working on Hepatology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Roel Sentjens has authored 12 papers receiving a total of 400 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hepatology, 9 papers in Epidemiology and 4 papers in Infectious Diseases. Recurrent topics in Roel Sentjens's work include Hepatitis C virus research (10 papers), Hepatitis B Virus Studies (7 papers) and Liver Disease Diagnosis and Treatment (5 papers). Roel Sentjens is often cited by papers focused on Hepatitis C virus research (10 papers), Hepatitis B Virus Studies (7 papers) and Liver Disease Diagnosis and Treatment (5 papers). Roel Sentjens collaborates with scholars based in Netherlands, United States and Germany. Roel Sentjens's co-authors include Xavier Forns, Markus Reiser, Gerhard Nehmiz, Heiner Wedemeyer, Holger Hinrichsen, Gerhard Steinmann, Andreas Erhardt, Ricardo L. Chaves, José Luís Calleja and Chan‐Loi Yong and has published in prestigious journals such as Gastroenterology, Hepatology and Journal of Clinical Microbiology.

In The Last Decade

Roel Sentjens

12 papers receiving 376 citations

Peers

Roel Sentjens
Rudolf A. Heijtink Netherlands
Annick Scholliers United States
Bandita Parhy United States
Ellen Xia United States
Eileen Z. Zhang United States
Ann M. Tigges United States
S Tanprasert Thailand
Roel Sentjens
Citations per year, relative to Roel Sentjens Roel Sentjens (= 1×) peers Yoann Morice

Countries citing papers authored by Roel Sentjens

Since Specialization
Citations

This map shows the geographic impact of Roel Sentjens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roel Sentjens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roel Sentjens more than expected).

Fields of papers citing papers by Roel Sentjens

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roel Sentjens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roel Sentjens. The network helps show where Roel Sentjens may publish in the future.

Co-authorship network of co-authors of Roel Sentjens

This figure shows the co-authorship network connecting the top 25 collaborators of Roel Sentjens. A scholar is included among the top collaborators of Roel Sentjens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roel Sentjens. Roel Sentjens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Sentjens, Roel, S. Houtman, Martijn R. Meijerink, & Thelma C. Konings. (2010). Emboli on the move. 14(6). 399–401. 1 indexed citations
2.
Hinrichsen, Holger, Yves Benhamou, Heiner Wedemeyer, et al.. (2004). Short-term antiviral efficacy of BILN 2061, a hepatitis C virus serine protease inhibitor, in hepatitis C genotype 1 patients. Gastroenterology. 127(5). 1347–1355. 233 indexed citations
3.
Weegink, Christine J., et al.. (2003). A physician with a positive hepatitis C virus RNA test after a needlestick injury. European Journal of Gastroenterology & Hepatology. 15(12). 1367–1369. 6 indexed citations
4.
Reiser, Markus, Holger Hinrichsen, Y. Benhamou, et al.. (2003). 136 Antiviral effect of BILN 2061, a novel HCV serine protease inhibitor, after oral treatment over 2 days in patients with chronic hepatitis C, non-genotype 1. Hepatology. 38. 221–221. 28 indexed citations
5.
Weegink, Christine J., Roel Sentjens, Marcel Beld, Marcel G. W. Dijkgraaf, & H. W. Reesink. (2003). Chronic hepatitis C patients with a post‐treatment virological relapse re‐treated with an induction dose of 18 MU interferon‐α in combination with ribavirin and amantadine: a two‐arm randomized pilot study. Journal of Viral Hepatitis. 10(3). 174–182. 16 indexed citations
6.
Sentjens, Roel, et al.. (2003). HGV/GB virus C transmission by blood components in patients undergoing open‐heart surgery. Transfusion. 43(11). 1558–1562. 7 indexed citations
7.
Sentjens, Roel, et al.. (2002). Viral kinetics of hepatitis C virus RNA in patients with chronic hepatitis C treated with 18 MU of interferon alpha daily. European Journal of Gastroenterology & Hepatology. 14(8). 833–840. 19 indexed citations
8.
Sentjens, Roel, et al.. (2002). Prevalence of and risk factors for HIV infection in blood donors and various population subgroups in Ethiopia. Epidemiology and Infection. 128(2). 221–228. 24 indexed citations
9.
Sentjens, Roel, et al.. (2002). HGV/GBV-C transmission by blood components in patients undergoing open-heart surgery. Journal of Hepatology. 36. 126–126. 1 indexed citations
11.
Sentjens, Roel, et al.. (2002). Rapid HCV RNA decline after daily 18 MU interferon induction combined with ribavirin and amantadine in chronic HCV patients. Journal of Hepatology. 36. 126–126. 1 indexed citations
12.
Beld, Marcel, Roel Sentjens, Sjoerd Rebers, et al.. (2000). Detection and Quantitation of Hepatitis C Virus RNA in Feces of Chronically Infected Individuals. Journal of Clinical Microbiology. 38(9). 3442–3444. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026